Standard Operating Procedures (SOPs)

The CTU has developed and is working by a set of standard operating procedures (SOPs). The list of procedures can be seen below:

Researchers collaborating with the CTU can gain access to the SOPs upon request.

  •  SOP #1.1 - Developing, approving, and updating SOPs

    • Appendix A - SOP template

    • Appendix B - SOP template instruction

    • Appendix C - SOP training of CTU staff

  • SOP #1.2 - Maintaining the CTU’s Master Index and files/folders for development plan and clinical trial files

  • SOP #1.3 - Contracts

    • Appendix A - Contract template (in English)

  • SOP #2.1 - Clinical trial development plan and protocol template

    • Appendix A - Protocol template

    • Appendix B - Request for protocol evaluation

    • Appendix C - Protocol evaluation form

  • SOP #2.2 - Intervention related documents

    • Appendix A - Content of the investigator's brochure in a trial on a medicinal product

    • Appendix B - Content of the investigational medicinal product dossier

    • Appendix C - Content of the investigator's brochure in a trial on a medical device

    • Appendix D - Content of the investigator's brochure in a trial on in vitro diagnostic medical device

  • SOP #2.3 - Participant information and informed consent

    • Appendix A - Content of participant information and informed consent form (in English)

    • Appendix B - Indhold af patientinformationsmateriale og samtykkeerklæring (in Danish)

    • Appendix C - Participant information and informed consent form template (in Danish)

  • SOP #2.4 - Participant insurance

  • SOP #2.5 - Clinical trial authorisation

    • Appendix A - Schematic of Danish clinical research authorisation procedures

    • Appendix B - Documents required for application for the authorisation of clinical trials to the Regional Ethics Committee

    • Appendix C - Documents required for application for the authorisation of clinical trials to the Danish Medicines Agency

    • Appendix D - Documents required for application for the authorisation of clinical investigations of medical devices to the Danish Medicines Agency

  • SOP #3.1 - Data management

    • Appendix A - Data management plan

    • Appendix B - Case Report Form (CRF) guidelines

SOP #3.2 - Randomisation and unblinding in clinical trials

  • Appendix A - Randomisation check list

  • Appendix B - Randomisation specification

  • Appendix C - Paper-based randomisation / emergency randomisation

  • Appendix D - Staff training in telephone-based randomisation and/or emergency randomisation

  • SOP #3.3 - Paper case report forms

  • SOP #3.4 - Electronic case report forms

    • Appendix A - eCRF validation

  • SOP #3.5 - Data Safety

  • SOP #4.1 - Data Monitoring Committee

  • SOP #4.2 - Adjudication Committees

  • SOP #5.1 - Filing and archiving of essential documents

    • Appendix A - Checklist of essential documents

    • Appendix B - Submitting data to the Danish Data Archive Health

  • SOP #5.2 - Monitoring of clinical trials

    • Appendix A - Checklist for pre-trial monitoring visits

    • Appendix B - Chekclist for initiation monitoring visits

    • Appendix C - Checklist for periodic monitoring visits

    • Appendix D - Checklist for closure monitoring/close-out visits

  • SOP #5.3 - Clinical trial amendments

    • Appendix A - Schematic overview of submission of amendments

    • Appendix B - Amendments to clinical trials on medicinal products

  • SOP #5.4 - Adverse events reporting

  • SOP #6.1 - Notification of end of trial

  • SOP #6.2 - Statistical analysis of clinical trials data

  • SOP #6.3 - Clinical trial reports

    • Appendix A – Structure and content of the clinical trial report (outside text)

  • SOP #7.1 - Escalation of problems and handling of scientific misconduct and/or dishonesty

  • SOP #7.2 - Qualification of trial staff

  • SOP #7.3 - Audits and inspection

    • Appendix A - What can be a subject to an audit?

  • SOP #8.1 - IT